Galanthamine HBr
CAS No. 1953-04-4
Galanthamine HBr( —— )
Catalog No. M13058 CAS No. 1953-04-4
Galanthamine hydrobromide is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 54 | In Stock |
|
| 25MG | 32 | In Stock |
|
| 50MG | 47 | In Stock |
|
| 100MG | 56 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 187 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGalanthamine HBr
-
NoteResearch use only, not for human use.
-
Brief DescriptionGalanthamine hydrobromide is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors.
-
DescriptionGalanthamine hydrobromide is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors.(In Vitro):Galanthamine hydrobromide is 53-fold selectivity for AChE over butyrylcholinesterase.Galanthamine hydrobromide (25-1000 μM) inhibits both Aβ 1-40 (50 μM) and Aβ 1-42 (50 μM) aggregation.Galanthamine hydrobromide (25-1000 μM) protects against Aβ(1-40) and Aβ(1-42) toxicity in SH-SY5Y cells.Galanthamine hydrobromide also dramatically reduces Aβ(1-40)-induced cellular apoptosis.(In Vivo):Galanthamine hydrobromide (1.25-2.5 mg/kg; i.p. ) reduces cognitive deficits in APP23 mice.Galanthamine hydrobromide (10 mg/kg; i.g.) displays short elimination half-life of approximately 2 h in wild-type mice.
-
In VitroGalanthamine hydrobromide is 53-fold selectivity for AChE over butyrylcholinesterase.Galanthamine hydrobromide (25-1000 μM) inhibits both Aβ 1-40 (50 μM) and Aβ 1-42 (50 μM) aggregation.Galanthamine hydrobromide (25-1000 μM) protects against Aβ(1-40) and Aβ(1-42) toxicity in SH-SY5Y cells.Galanthamine hydrobromide also dramatically reduces Aβ(1-40)-induced cellular apoptosis.
-
In VivoGalanthamine hydrobromide (1.25-2.5 mg/kg; i.p. ) reduces cognitive deficits in APP23 mice.Galanthamine hydrobromide (10 mg/kg; i.g.) displays short elimination half-life of approximately 2 h in wild-type mice. Animal Model:APP23 mice Dosage:1.25 mg/kg, 2.5 mg/kg Administration:Intraperitoneal injection, daily, 1 week Result:Effectively remedied the spatial learning deficit.Animal Model:Female 57B1/6J wild type Dosage:10 mg/kg Administration:Oral gavage (Pharmacokinetic Analysis)Result:Cmax (0.31 μg/mL), t1/2β (1.6 h), AUC0-24h (0.67 μg ? h/mL).
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChE
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1953-04-4
-
Formula Weight368.27
-
Molecular FormulaC17H21NO3·HBr
-
Purity>98% (HPLC)
-
SolubilityWater: 36 mg/mL (97.75 mM)
-
SMILESCN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O.Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thomsen T, et al. Eur J Clin Chem Clin Biochem, 1991, 29(8), 487-492.
molnova catalog
related products
-
Atropine sulfate mon...
Atropine sulfate monohydrate is a competitive muscarinic acetylcholine receptor antagonist.
-
Hypaphorine
Hypaphorine is an indole-3-acetic acid antagonist which specifically compete with indole-3-acetic acid in binding to the indole-3-acetic acid-binding site in plant peroxidases.
-
JHU 37160
JHU 37160 is a Designer Receptors Exclusively Activated by Designer Drug (DREADD) agonist with Ki of 1.9 nM and 3.6 nM for human muscarinic acetylcholine M3 receptors (hM3Dq) and hM4Di in vitro, respectively.
Cart
sales@molnova.com